CY1114179T1 - Ανοσοποιηση εναντι μηνιγγιτιδοκοκκου οροομαδας υ με χρηση πρωτεϊνων - Google Patents

Ανοσοποιηση εναντι μηνιγγιτιδοκοκκου οροομαδας υ με χρηση πρωτεϊνων

Info

Publication number
CY1114179T1
CY1114179T1 CY20131100353T CY131100353T CY1114179T1 CY 1114179 T1 CY1114179 T1 CY 1114179T1 CY 20131100353 T CY20131100353 T CY 20131100353T CY 131100353 T CY131100353 T CY 131100353T CY 1114179 T1 CY1114179 T1 CY 1114179T1
Authority
CY
Cyprus
Prior art keywords
immunization against
serum
protein use
immunization
against professional
Prior art date
Application number
CY20131100353T
Other languages
English (en)
Inventor
Mario Contorni
Marzia Giuliani
Mariagrazia Pizza
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32344210&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CY1114179(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CY1114179T1 publication Critical patent/CY1114179T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Abstract

Το καθιερωμένο δόγμα για μηνιγγιτιδόκοκκο είναι επομένως ότι η ανοσοποίηση κατά οροομάδων A, C, W135 και Υ θα βασισθεί σε τέσσερεις διαφορετικούς καψικούς σακχαρίτες, και ότι η ανοσοποίηση κατά οροομάδας Β δεν θα βασισθεί στον καψικό σακχαρίτη. Αντιθέτως, η εφεύρεση χρησιμοποιεί πολυπεπτιδικά αντιγόνα και/ή OMVs για ανοσοποίηση κατά οροομάδων A, C, W135 και Υ (και ιδιαιτέρως έναντι οροομάδας Υ). Τα πολυπεπτίδια οροομάδας Β μπορούν να επιτύχουν αυτή την προστασία επιτρέποντας έτσι ένα εμβόλιο βασισμένο σε ένα μόνο πολυπεπτίδιο να χρησιμοποιηθεί για προστασία έναντι όλων των οροομάδων Α, Β, C, W 135 και Υ.
CY20131100353T 2004-04-22 2013-04-29 Ανοσοποιηση εναντι μηνιγγιτιδοκοκκου οροομαδας υ με χρηση πρωτεϊνων CY1114179T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0408977.7A GB0408977D0 (en) 2004-04-22 2004-04-22 Immunising against meningococcal serogroup Y using proteins
EP05733998.8A EP1737486B2 (en) 2004-04-22 2005-04-22 Immunising against meningococcal serogroup y using proteins

Publications (1)

Publication Number Publication Date
CY1114179T1 true CY1114179T1 (el) 2016-08-31

Family

ID=32344210

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20131100353T CY1114179T1 (el) 2004-04-22 2013-04-29 Ανοσοποιηση εναντι μηνιγγιτιδοκοκκου οροομαδας υ με χρηση πρωτεϊνων

Country Status (14)

Country Link
US (1) US10195264B2 (el)
EP (1) EP1737486B2 (el)
JP (2) JP4918479B2 (el)
CN (1) CN1946420B (el)
AU (1) AU2005235265A1 (el)
BR (1) BRPI0510104A8 (el)
CA (1) CA2566509C (el)
CY (1) CY1114179T1 (el)
ES (1) ES2401481T5 (el)
GB (1) GB0408977D0 (el)
MX (1) MXPA06012041A (el)
PT (1) PT1737486E (el)
RU (1) RU2378009C2 (el)
WO (1) WO2005102384A2 (el)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7368261B1 (en) 1999-04-30 2008-05-06 Novartis Vaccines And Diagnostics Srl Conserved Neisserial antigens
DK2270173T3 (en) 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
CN1800385B (zh) * 2000-02-28 2010-06-02 启龙有限公司 奈瑟球菌蛋白质的异源表达
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
PT2255826E (pt) * 2002-08-02 2016-06-08 Glaxosmithkline Biologicals Sa Composições de vacina de neisseria compreendendo uma combinação de antigénios
ES2608048T3 (es) * 2002-10-11 2017-04-05 Glaxosmithkline Biologicals Sa Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
NZ594482A (en) * 2005-11-04 2012-11-30 Novartis Vaccines & Diagnostic Influenza vaccines with reduced amount of oil-in-water emulsion as adjuvant
GB0524066D0 (en) * 2005-11-25 2006-01-04 Chiron Srl 741 ii
AR058707A1 (es) 2005-12-22 2008-02-20 Glaxosmithkline Biolog Sa Vacuna, procedimiento para fabricarla y su uso
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
EA200901578A1 (ru) 2007-06-26 2010-08-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина, содержащая конъюгаты капсульных полисахаридов streptococcus pneumoniae
AU2010227219B2 (en) 2009-03-24 2014-02-27 Glaxosmithkline Biologicals S.A. Adjuvanting meningococcal factor H binding protein
JP5668049B2 (ja) * 2009-03-24 2015-02-12 ノバルティス アーゲー 髄膜炎菌ｈ因子結合タンパク質および肺炎球菌糖結合体の組み合わせ
CA2772104A1 (en) * 2009-08-27 2011-03-03 Novartis Ag Hybrid polypeptides including meningococcal fhbp sequences
WO2011027956A2 (ko) 2009-09-04 2011-03-10 주식회사이언메딕스 그람 양성 박테리아에서 유래한 세포밖 소포체 및 이를 이용한 질병 모델
EP2494865A4 (en) 2009-09-01 2014-05-14 Aeon Medix Inc EXTRACELLULAR VESICLES OBTAINED FROM THE DARMFLORA, AND METHOD FOR SEARCHING FOR A DISEASE MODEL, VACCINE AND CANDIDATE AND DIAGNOSTIC METHOD THEREFOR
ES2910199T3 (es) 2010-03-30 2022-05-11 Childrens Hospital & Res Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas
HUE052850T2 (hu) 2010-08-23 2021-05-28 Wyeth Llc Neisseria meningitidis RLP2086 antigéneket tartalmazó stabil készítmények
NZ607224A (en) 2010-09-10 2014-11-28 Wyeth Llc Non-lipidated variants of neisseria meningitidis orf2086 antigens
SA115360586B1 (ar) 2012-03-09 2017-04-12 فايزر انك تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها
KR101763625B1 (ko) 2012-03-09 2017-08-01 화이자 인코포레이티드 수막염균 조성물 및 이의 사용 방법
NZ630133A (en) * 2012-06-14 2016-10-28 Novartis Ag Vaccines for serogroup x meningococcus
WO2014016152A1 (en) 2012-07-27 2014-01-30 Institut National De La Sante Et De La Recherche Medicale Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
ES2685894T3 (es) 2013-03-08 2018-10-15 Pfizer Inc. Polipéptidos de fusión inmunogénicos
RU2662968C2 (ru) 2013-09-08 2018-07-31 Пфайзер Инк. Иммуногенная композиция против neisseria meningitidis (варианты)
EP4074726A3 (en) 2014-07-23 2022-11-23 Children's Hospital & Research Center at Oakland Factor h binding protein variants and methods of use thereof
EP3270959A1 (en) 2015-02-19 2018-01-24 Pfizer Inc Neisseria meningitidis compositions and methods thereof
CA3035320A1 (en) 2016-09-02 2018-03-08 Glaxosmithkline Biologicals Sa Vaccines for neisseria gonorrhoeae
SG11201906519RA (en) 2017-01-31 2019-08-27 Pfizer Neisseria meningitidis compositions and methods thereof

Family Cites Families (94)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4309095A (en) 1980-11-03 1982-01-05 Buckley Frederick P Camera mounting device
US4356170A (en) 1981-05-27 1982-10-26 Canadian Patents & Development Ltd. Immunogenic polysaccharide-protein conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
US4459286A (en) 1983-01-31 1984-07-10 Merck & Co., Inc. Coupled H. influenzae type B vaccine
US4663160A (en) 1983-03-14 1987-05-05 Miles Laboratories, Inc. Vaccines for gram-negative bacteria
US4761283A (en) 1983-07-05 1988-08-02 The University Of Rochester Immunogenic conjugates
US4808700A (en) 1984-07-09 1989-02-28 Praxis Biologics, Inc. Immunogenic conjugates of non-toxic E. coli LT-B enterotoxin subunit and capsular polymers
EP0273116A3 (en) 1986-10-09 1990-05-02 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Gonococcal and meningococcal polypeptides, vaccines and diagnostics
NO882936D0 (no) * 1987-07-07 1988-07-01 Nl Mini Welzijn Gesund Cultur Flerverdig meningokokkvaksine.
RU2023448C1 (ru) 1987-07-30 1994-11-30 Сентро Насьональ Де Биопрепарадос Способ получения вакцины против различных патогенных серотипов менингита нейссера группы в
US4835621A (en) 1987-11-04 1989-05-30 Black John W Gun mounted video camera
NL8802046A (nl) 1988-08-18 1990-03-16 Gen Electric Polymeermengsel met polyester en alkaansulfonaat, daaruit gevormde voorwerpen.
NL8803111A (nl) 1988-12-19 1990-07-16 Nederlanden Staat Multivalent meningococcen klasse i buitenmembraaneiwit vaccin.
AU640118B2 (en) 1988-12-19 1993-08-19 De Staat Der Nederlanden Vertegenwoordigd Door De Minister Van Welzijn, Volksgezonheid En Cultuur Meningococcal class 1 outer-membrane protein vaccine
DK130889A (da) 1989-03-17 1990-09-18 Mogens Kilian Immunoglobulin a1-proteaser (iga1-proteaser), fremgangsmaade til genteknologisk fremstilling af saadanne enzymer samt vaccine indeholdende enzymerne og fragmenter deraf til immunisering mod bakteriel meningitis og andre sygdomme fremkaldt af iga1-protease-producerende bakterier
IE912559A1 (en) 1990-07-19 1992-01-29 Merck & Co Inc The class ii protein of the outer membrane of neisseria¹meningitidis, and vaccines containing same
US5020262A (en) 1990-09-04 1991-06-04 Pena Louis T Camera mount for rifle scopes
CA2105382C (en) 1991-03-14 1999-01-19 Neil Goldstein Recombinant hybrid porin epitopes
FR2692592B1 (fr) 1992-06-19 1995-03-31 Pasteur Merieux Serums Vacc Fragments d'ADN codant pour les sous-unités du récepteur de la transferrine de Neisseria meningitidis et procédés les exprimant.
NL9201716A (nl) 1992-10-02 1994-05-02 Nederlanden Staat Buitenmembraanvesikel dat voorzien is van een groep polypeptiden welke ten minste de immuunwerking van aan membraan gebonden buitenmembraaneiwitten (OMP's) hebben, werkwijze ter bereiding ervan alsmede een vaccin dat een dergelijk buitenmembraanvesikel omvat.
US5439808A (en) 1993-07-23 1995-08-08 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane group B porin proteins from Neisseria meningitidis
FR2720408B1 (fr) 1994-05-31 1996-08-14 Pasteur Merieux Serums Vacc Fragments Tbp2 de Neisseria meningitidis.
IL117483A (en) 1995-03-17 2008-03-20 Bernard Brodeur MENINGITIDIS NEISSERIA shell protein is resistant to proteinase K.
US6180111B1 (en) 1995-05-18 2001-01-30 University Of Maryland Vaccine delivery system
FR2739624B1 (fr) 1995-10-10 1997-12-05 Pasteur Merieux Serums Vacc Nouvelle sous-unite tbp2 de neisseria meningitidis
EP0939647B2 (en) 1996-08-27 2006-07-12 Chiron Corporation Neisseria meningitidis serogroup b glycoconjugates and methods of using the same
US6472518B1 (en) 1996-10-24 2002-10-29 Centers For Disease Control And Prevention, As Represented By The Secretary, Department Of Health And Human Services Invasion associated genes from Neisseria meningitidis serogroup B
GB9711964D0 (en) 1997-06-09 1997-08-06 Medical Res Council Live attenuated vaccines
US6914131B1 (en) 1998-10-09 2005-07-05 Chiron S.R.L. Neisserial antigens
ATE476508T1 (de) 1997-11-06 2010-08-15 Novartis Vaccines & Diagnostic Neisseriale antigene
US5887375A (en) 1997-11-19 1999-03-30 Watson; Jerry Wade Camera mount for firearms
GB9726398D0 (en) 1997-12-12 1998-02-11 Isis Innovation Polypeptide and coding sequences
EP2210945B1 (en) 1998-01-14 2013-06-26 Novartis Vaccines and Diagnostics S.r.l. Neisseria meningitidis antigens
US20070026021A1 (en) * 1998-05-01 2007-02-01 Chiron S.R.I. Neisseria meningitidis antigens and compositions
NZ508366A (en) 1998-05-01 2004-03-26 Chiron Corp Neisseria meningitidis antigens and compositions
BR9914374A (pt) * 1998-10-09 2002-09-17 Chiron Corp Sequências genÈmicas de neisseria e métodos para seu uso
US6146902A (en) 1998-12-29 2000-11-14 Aventis Pasteur, Inc. Purification of polysaccharide-protein conjugate vaccines by ultrafiltration with ammonium sulfate solutions
US6425697B1 (en) 1999-03-17 2002-07-30 Jeff C. Potts Universal camera mounting assembly
JP2003527079A (ja) 1999-04-30 2003-09-16 カイロン コーポレイション ナイセリアゲノム配列およびそれらの使用方法
US7368261B1 (en) 1999-04-30 2008-05-06 Novartis Vaccines And Diagnostics Srl Conserved Neisserial antigens
DK2270173T3 (en) * 1999-05-19 2016-03-07 Glaxosmithkline Biolog Sa Neisserial combination compositions
US6192614B1 (en) 1999-07-23 2001-02-27 Daniel Cliburn Video mounting system for firearm
GB9918319D0 (en) 1999-08-03 1999-10-06 Smithkline Beecham Biolog Vaccine composition
MXPA02004283A (es) 1999-10-29 2002-10-17 Chiron Spa Peptidos antigenicos neisseriales.
GB9928196D0 (en) * 1999-11-29 2000-01-26 Chiron Spa Combinations of B, C and other antigens
CN1433471A (zh) * 1999-11-29 2003-07-30 启龙股份公司 85kgDa奈瑟球菌的抗原
DK1248647T3 (da) * 2000-01-17 2010-09-27 Novartis Vaccines & Diagnostic Ydre membranvesikel (OMV) vaccine omfattende N. meningitidis serogruppe B ydre membranproteiner
CZ304379B6 (cs) 2000-01-25 2014-04-09 The University Of Queensland Proteiny obsahující konzervované oblasti povrchového antigenu NhhA z Neisseria meningitidis
CN1800385B (zh) 2000-02-28 2010-06-02 启龙有限公司 奈瑟球菌蛋白质的异源表达
MXPA03000822A (es) 2000-07-27 2004-11-01 Childrens Hosp & Res Ct Oak Vacunas para proteccion de espectro amplio contra enfermedades causadas por neisseria meningitidis.
GB0103170D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
CA2435681C (en) 2001-01-23 2011-06-21 Aventis Pasteur Multivalent meningococcal polysaccharide-protein conjugate vaccine
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
GB0115176D0 (en) 2001-06-20 2001-08-15 Chiron Spa Capular polysaccharide solubilisation and combination vaccines
EP1409013B1 (en) * 2001-07-26 2009-11-18 Novartis Vaccines and Diagnostics S.r.l. Vaccines comprising aluminium adjuvants and histidine
GB0118249D0 (en) * 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
GB0121591D0 (en) 2001-09-06 2001-10-24 Chiron Spa Hybrid and tandem expression of neisserial proteins
ES2615362T3 (es) 2001-07-27 2017-06-06 Glaxosmithkline Biologicals Sa Adhesinas de meningococos
AR045702A1 (es) 2001-10-03 2005-11-09 Chiron Corp Composiciones de adyuvantes.
MX339524B (es) 2001-10-11 2016-05-30 Wyeth Corp Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica.
PT2255826E (pt) 2002-08-02 2016-06-08 Glaxosmithkline Biologicals Sa Composições de vacina de neisseria compreendendo uma combinação de antigénios
GB0220197D0 (en) 2002-08-30 2002-10-09 Univ Utrecht Refolding method
US7785608B2 (en) * 2002-08-30 2010-08-31 Wyeth Holdings Corporation Immunogenic compositions for the prevention and treatment of meningococcal disease
ES2608048T3 (es) * 2002-10-11 2017-04-05 Glaxosmithkline Biologicals Sa Vacunas polipeptídicas para protección amplia contra linajes meningocócicos hipervirulentos
GB0227346D0 (en) 2002-11-22 2002-12-31 Chiron Spa 741
EP1590459A2 (en) 2003-01-15 2005-11-02 Wyeth Holdings Corporation Methods for increasing neisseria protein expression and compositions thereof
CA2514328C (en) 2003-01-30 2020-01-14 Chiron Srl Injectable vaccines against multiple meningococcal serogroups
JP2006525330A (ja) 2003-04-16 2006-11-09 ワイエス・ホールディングス・コーポレーション 髄膜炎菌性疾患の予防および処置のための新規免疫原性組成物
US7731967B2 (en) 2003-04-30 2010-06-08 Novartis Vaccines And Diagnostics, Inc. Compositions for inducing immune responses
GB0315021D0 (en) * 2003-06-26 2003-07-30 Chiron Srl Immunogenic gonococcal compositions
DK1961426T3 (da) * 2003-10-02 2011-08-08 Novartis Ag Kombinationsvacciner mod meningitis
GB0408977D0 (en) * 2004-04-22 2004-05-26 Chiron Srl Immunising against meningococcal serogroup Y using proteins
GB0409748D0 (en) 2004-04-30 2004-06-09 Chiron Srl Lactoferrin cleavage
GB0419408D0 (en) * 2004-09-01 2004-10-06 Chiron Srl 741 chimeric polypeptides
GB0419627D0 (en) * 2004-09-03 2004-10-06 Chiron Srl Immunogenic bacterial vesicles with outer membrane proteins
CN101107007B (zh) 2005-01-27 2011-08-17 奥克兰儿童医院及研究中心 对脑膜炎奈瑟球菌所致疾病具有广谱保护作用的gna1870囊泡疫苗
CA2611960C (en) * 2005-06-27 2015-05-05 Glaxosmithkline Biologicals S.A. Immunogenic compositions comprising n.meningitidis capsular saccharide conjugates
GB0524066D0 (en) 2005-11-25 2006-01-04 Chiron Srl 741 ii
TW200806315A (en) 2006-04-26 2008-02-01 Wyeth Corp Novel formulations which stabilize and inhibit precipitation of immunogenic compositions
BRPI0713904A2 (pt) * 2006-06-29 2013-06-25 Novartis Ag polipeptÍdeos a partir de neisseria meningitidis
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
AR064642A1 (es) 2006-12-22 2009-04-15 Wyeth Corp Polinucleotido vector que lo comprende celula recombinante que comprende el vector polipeptido , anticuerpo , composicion que comprende el polinucleotido , vector , celula recombinante polipeptido o anticuerpo , uso de la composicion y metodo para preparar la composicion misma y preparar una composi
US20100150912A1 (en) 2007-04-11 2010-06-17 Novartis Ag Blocking interaction between pathogen factors and factor h to inhibit hemorrhagic syndromes
MX2009013112A (es) 2007-06-04 2010-03-01 Novartis Ag Formulacion de vacunas para meningitis.
CA2716212A1 (en) 2008-02-21 2009-08-27 Novartis Ag Meningococcal fhbp polypeptides
EP2265640B1 (en) 2008-03-10 2015-11-04 Children's Hospital & Research Center at Oakland Chimeric factor h binding proteins (fhbp) containing a heterologous b domain and methods of use
US20100035234A1 (en) * 2008-05-19 2010-02-11 Novartis Ag Vaccine assays
WO2010028096A2 (en) 2008-09-03 2010-03-11 Children's Hospital & Research Center At Oakland Peptides presenting an epitope of an a domain of factor h binding protein and methods of use
IT1394288B1 (it) 2008-09-12 2012-06-06 Novartis Vaccines & Diagnostic Immunogeni di proteine che legano il fattore h.
GB0819633D0 (en) 2008-10-25 2008-12-03 Isis Innovation Composition
AU2010227219B2 (en) 2009-03-24 2014-02-27 Glaxosmithkline Biologicals S.A. Adjuvanting meningococcal factor H binding protein
JP2013521327A (ja) 2010-03-10 2013-06-10 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
ES2910199T3 (es) 2010-03-30 2022-05-11 Childrens Hospital & Res Center At Oakland Proteínas de unión al factor H (fHbp) con propiedades alteradas y métodos de uso de las mismas
AU2011300418B2 (en) 2010-09-10 2016-05-12 Glaxosmithkline Biologicals Sa Meningococcus overexpressing NadA and/or NHBA and outer membrane vesicles derived therefrom

Also Published As

Publication number Publication date
MXPA06012041A (es) 2007-01-25
WO2005102384A2 (en) 2005-11-03
JP2011105777A (ja) 2011-06-02
JP4918479B2 (ja) 2012-04-18
GB0408977D0 (en) 2004-05-26
JP2007533729A (ja) 2007-11-22
EP1737486B2 (en) 2022-12-28
WO2005102384A3 (en) 2006-03-23
US20100143418A1 (en) 2010-06-10
AU2005235265A1 (en) 2005-11-03
RU2006140958A (ru) 2008-05-27
RU2378009C2 (ru) 2010-01-10
PT1737486E (pt) 2013-05-15
US10195264B2 (en) 2019-02-05
CN1946420B (zh) 2011-02-16
BRPI0510104A8 (pt) 2018-04-03
EP1737486A2 (en) 2007-01-03
ES2401481T5 (es) 2023-05-16
BRPI0510104A (pt) 2007-09-25
CA2566509C (en) 2018-07-17
EP1737486B1 (en) 2013-02-27
CN1946420A (zh) 2007-04-11
ES2401481T3 (es) 2013-04-22
CA2566509A1 (en) 2005-11-03

Similar Documents

Publication Publication Date Title
CY1114179T1 (el) Ανοσοποιηση εναντι μηνιγγιτιδοκοκκου οροομαδας υ με χρηση πρωτεϊνων
CY1113020T1 (el) Εμβολια συνδυασμου για neisseria meningitidis
CY1117689T1 (el) Συνθεσεις που περιλαμβανουν πνευμονιοκοκκικα αντιγονα
CY1123400T1 (el) Ανθρωπινα anti-il-23 αντισωματα, συνθεσεις, μεθοδοι και χρησεις
CY1110225T1 (el) Κυκλικοι αναστολεις πρωτεϊνικης τυροσινικης κινασης
CY1120328T1 (el) Συνθεση εμβολιου περιεχουσα συνθετικο ανοσοενισχυτικο
ATE513560T1 (de) Kombinationsimpfstoff gegen bakterielle meningitis, der über die schleimhaut appliziert wird
AR054474A1 (es) Formulacion de anticuerpos estables
CY1117957T1 (el) Συμπληρωμενο omv εμβολιο εναντι μηνιγγιοκοκκου
CY1118732T1 (el) Εμβολια κυστιδιων βασει gna1870 για προστασια ευρεως φασματος εναντι νοσων προκαλουμενων απο neisseria meningitidis
CY1106431T1 (el) Γονοκοκκικες πρωτεϊνες και νουκλεϊκα οξεα
NO20026121L (no) Streptokokkantigener
CY1118492T1 (el) Φαρμακοτεχνικες μορφες εμβολιου norovirus
CY1114722T1 (el) Αντιγονα στρεπτοκοκκου
DK1549338T3 (da) Polypeptidvacciner til bred beskyttelse mod hypervirulente meningokok-afstamningslinier
NO20063254L (no) Immunstimulerende sammensetning omfattende minst en toll-lignende reseptor 7 eller toll-lignende reseptor 8 agonist og en toll-lignende reseptor 4 agonist
BRPI0407101A (pt) Vacinas meningocócicas mucosais
RU2017123262A (ru) Иммуногенные композиции для применения в пневмококковых вакцинах
DK1235589T3 (da) Præparater der omfatter neisseria meningitidis-antigener fra serogruppe B og C samt et yderligere antigen
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
CY1106876T1 (el) Συσκευασια και μεθοδος ανιχνευσεως της πρωτεϊνης esm-1
MA29459B1 (fr) Vaccins
BR112022011032A2 (pt) Conjugado de anticorpo-fármaco anti-claudina e uso farmacêutico do mesmo
TR200103012T2 (tr) Yeni kompozisyonlar